uniQure NV is a gene therapy company. It develops treatment and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipel... uniQure NV is a gene therapy company. It develops treatment and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. 詳細を表示
~ Type B meeting scheduled with the FDA in the fourth quarter of 2024 to initiate discussions regarding a potential expedited clinical development pathway for AMT-130 in Huntington’s disease ~ ~...
LEXINGTON, Mass. and AMSTERDAM, Oct. 15, 2024 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical...
LEXINGTON, Mass. and AMSTERDAM, Sept. 23, 2024 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 1.72 | 31.5596330275 | 5.45 | 7.96 | 5.35 | 1020243 | 7.28783362 | CS |
4 | 1.53 | 27.1276595745 | 5.64 | 7.96 | 5.35 | 740458 | 6.6500069 | CS |
12 | 0.59 | 8.96656534954 | 6.58 | 7.96 | 4.45 | 658636 | 5.96179016 | CS |
26 | 2.24 | 45.4361054767 | 4.93 | 11.35 | 3.73 | 1767513 | 7.69065319 | CS |
52 | 1.16 | 19.3011647255 | 6.01 | 11.35 | 3.73 | 1395897 | 7.07138691 | CS |
156 | -25.85 | -78.285887341 | 33.02 | 33.03 | 3.73 | 960334 | 11.83114873 | CS |
260 | -46.62 | -86.6703848299 | 53.79 | 76.6869 | 3.73 | 768663 | 20.05929658 | CS |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約